Medicamen Biotech has planned a shutdown of its plant at Bhiwadi in the state of Rajasthan for 45 days. During the shutdown, the company intends to upgrade the plant for inspection from organization like UNICEF, UNDP, UNOPS etc., and other International NGOs.
This up-gradation will enable the company to prepare for regulated market and also provide next level of growth in terms of good volume business with better margins.
Medicamen Biotech is engaged in manufacturing and marketing of pharmaceutical formulations in overseas and domestic markets.
